RecruitingNot ApplicableNCT05453721

Effect and Long-Term Outcomes of Indocyanine Green Fluorescence Imaging Method Versus Modified Inflation-Deflation Method in Identification of Intersegmental Plane(IMPLANE-0529)

Effect and Long-Term Outcomes of Indocyanine Green Fluorescence Imaging Method Versus Modified Inflation-Deflation Method in Identification of Intersegmental Plane: A Multicenter、Prospective、Randomized Controlled Trial


Sponsor

The First Affiliated Hospital of Nanchang University

Enrollment

272 participants

Start Date

Aug 4, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

This study is a multi-center, prospective, randomized controlled clinical trial. The purpose is to compare the difference of indocyanine green fluorescence imaging method and modified inflation-deflation method in identifying intersegmental plane in segmentectomy, and provide high-level evidence for the selection of intersegmental plane identification method in early NSCLC segmental resection.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Inclusion Criteria9

  • Aged 18 to 80 years old;
  • According to the surgical standards of the Eighth edition of People's Medical Publishing House, patients whose blood pressure was under 160/100mmHg and blood glucose was under 5.6-11.2mmol /L with normal functions of major organs such as heart, lung, liver and kidney before surgery are included. The main criteria are as follows:
  • i. Cardiac function examination indicated Goldman index grade 1-2; ii. Pulmonary function examination suggested postoperative predicted FEV1≥40% and DLCO≥40%; iii. Total bilirubin ≤1.5 times the upper limit of normal; iv. Alanine aminotransferase and aspartate aminotransferase ≤2.5 times the upper limit of normal value; v. Creatinine ≤1.25 times the upper limit of normal value and creatinine clearance ≥60ml/min;
  • The center of the lesion is located in the other lobes except the middle lobe, and in the middle and outer third of the lung;
  • The maximum diameter of the tumor was not more than 2cm on TLC(Thin layer CT) scan and the clinical stage was cT1a-1bN0M0(according to AJCC staging criteria, eighth edition);
  • Consolidation tumor rate \<1;
  • ECOG PSscore 0-1;
  • All relevant examinations should be completed within 28 days before surgery;
  • Patients who understand the study and have signed informed consent.

Exclusion Criteria12

  • Patient with a history of iodine or indocyanine green allergy;
  • Patient who had received antitumor therapy (radiotherapy, chemotherapy, targeted therapy, immunotherapy) prior to surgery;
  • Patient with a history of other malignancies;
  • Patient with secondary primary cancer at enrollment;
  • Small cell lung cancer;
  • Prior history of unilateral thoracotomy;
  • Woman in pregnant or breastfeeding period;
  • Patient with interstitial pneumonia, pulmonary fibrosis or severe emphysema;
  • An active bacterial or fungal infection that is difficult to control;
  • Severe mental illness;
  • History of severe heart disease , heart failure , myocardial infarction or angina pectoris within the last 6 months;
  • patient that researcher considers inappropriate to participate in this study.

Interventions

PROCEDUREIndocyanine green fluorescence imaging method

Using indocyanine green fluorescence imaging method to identify intersegmental plane in segmentectomy

PROCEDUREModified inflation-deflation method

Using modified inflation-deflation method to identify intersegmental plane in segmentectomy


Locations(1)

The First Affiliated Hospital of Nanchang University

Nanchang, Jiangxi, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05453721


Related Trials